# FDA Inspection 1102130 - EyePoint Pharmaceuticals, Inc. - August 28, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/eyepoint-pharmaceuticals-inc/bd40ecfd-6d7a-4c39-8319-1d042041f48b
Source feed: FDA_Inspections

> FDA Inspection 1102130 for EyePoint Pharmaceuticals, Inc. on August 28, 2019. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102130
- Company Name: EyePoint Pharmaceuticals, Inc.
- Inspection Date: 2019-08-28
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1150669 - 2021-09-01](https://www.globalkeysolutions.net/records/fda_inspections/eyepoint-pharmaceuticals-inc/bc7824a1-722e-4a03-8af8-91a2affaaa96)

Company: https://www.globalkeysolutions.net/companies/eyepoint-pharmaceuticals-inc/ca6562a2-b315-4e33-b9b2-394c1c8ad945

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c